Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Daiichi Sankyo has introduced percutaneous analgesic and anti-inflammatory drug Loxonin gel 1% in Japan.
Subscribe to our email newsletter
Loxonin gel 1% contains the same active ingredient, loxoprofen sodium hydrate as found in pills and powder formulations of the oral analgesic and anti-inflammatory Loxonin brand.
Daiichi Sankyo claimed that the Loxonin gel 1% offers equivalent efficacy and can be easily applied to an affected area with no displeasing odor.
The company said that following the launch of Loxonin pap in 2006 and Loxonin tape in 2008, it is confident that this new addition to the Loxonin lineup will further contribute to analgesic and anti-inflammatory drug treatment in Japan.